Search details
1.
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.
Br J Cancer
; 114(8): 889-96, 2016 Apr 12.
Article
in English
| MEDLINE | ID: mdl-27002938
2.
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.
Clin Cancer Res
; 29(22): 4555-4563, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37643133
3.
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35499204
Results
1 -
3
de 3
1
Next >
>>